Tribute to Steve Jobs on Apple's Home Page.

Apple Loses Its Hero

Cupertino, CA (Scicasts) -- "I have some very sad news to share with all of you. Steve passed away earlier today." This was the sad statement written by Apple's newly appointed CEO, Tim Cook on October 5th, in a letter sent to Apple's staff.

The State of the Union: President Obama's Plan to Win the Future.

Obama Calls for Science, Technology and Education to Boost Future Economic Growth

Washington, DC (Scicasts) - In his State of the Union address to Congress on Tuesday night (January 25th), President Obama spoke of the need to maintain America’s leadership in a rapidly changing world so that the country's economy is competitive. The emphasis in his speech was on outperforming America's global competitors – particularly the emerging economies – through science, technology and innovation, as well as education. Below is the summary of his speech in relation to his science and technology plans.

Nanotechnology - A Financial Perspective from Zurich

Zurich Financial Services Group focuses on Nanotechnology in its latest issue of Industry Insight, its online consumer magazine. It defines nanotechnology as the methods of manipulating atoms and molecules to create new structures at scales measured in billionths of a metre. This issue of Industry Insight provides an overview of nanotechnology today – its enormous commercial potential, the unique risk challenges nanotechnology poses, the regulatory environment for nanotechnology, and a look at what Zurich is doing to help its customers understand and manage the potential risk.

Scicasts Story

Decoding Humans – Where Are We Now?

Gone are the days where people could be just reactive on their diseases. Now they can be proactive too. Advancements in genetic technologies offer a new ray of hope for people to understand what their genome has got to offer in their lifetime. Easier said than done, current progresses in this field look positive in spite of inherent challenges like cost, privacy and other associated regulatory and application hurdles.
Scicasts Story

Stem Cells Technology and NPOs in Drug Discovery

In the current economic gloom, it is very tempting to write another run-of-the-mill article about how the credit crisis is affecting the pharmaceutical industry and the healthcare domain as a whole. However, since those issues have been covered and belabored threadbare in most other journals, this article will focus on some of the other interesting things that are happening in the industry.

Scicasts Story

The European HIV/AIDS Market – an Outlook

Europe is the second largest market for HIV/AIDS therapeutics after the US market. However, it is also a very challenging market for pharmaceutical manufacturers because of the differences in policies across the region. The European HIV/AIDS market poses unique challenges to the manufacturers as well as the public health authorities.

Scicasts Story

The Past, Present and Future of the European Drug Discovery

Increasing costs, a limited drug pipeline and the impeding loss of patent coverage for ‘blockbuster’ drugs are changing the landscape of pharmaceutical science. Certain business strategies will need to be employed to overcome these challenges.

Scicasts Story

Bio-IT and Biotechnology Outlook for 2009

Looking back at 2008, we witnessed many upturns as well as downturns that will influence the performance of the biotechnology industry in 2009. We will be keeping a close eye on all the events of the year with particular attention on the financial developments in the biopharmaceutical sectors and how Bio-IT will fit in.
Scicasts Story

Diagnostics - Its crucial time

In-vitro diagnostics is in the midst of a major change. Last year, the IVD industry was the centre of media attention as it witnessed one of the largest industry consolidations within the healthcare sector. The entry of medical technology giant Siemens and the aspirations of GE to enter this market, have heightened this interest, as the IVD industry is traditionally considered a low-profit business in the life sciences space.

Scicasts Story

Breast MRI: Will it Lead to an End in Surgeries?

What is the benefit of a breast MRI? Why use breast MRI and not a mammogram? These are some of the questions that face many patients when they are asked to undergo a breast MRI. Thus, it is very important to understand this procedure from the patient’s perspective to bring out its utility in the best possible manner.